S
SELLAS Life Sciences Group, Inc. (SLS)
NCM – Real vaqt narxi. Valyuta: USD
5.22
-0.03 (-0.57%)
Yopilishda: May 12, 2026, 4:00 PM EDT
Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling
Find any stock by ticker or company name
NCM – Real vaqt narxi. Valyuta: USD
5.22
-0.03 (-0.57%)
Yopilishda: May 12, 2026, 4:00 PM EDT
SELLAS Life Sciences Group, Inc., kechki bosqichdagi klinik biofarmatsevtika kompaniyasi bo'lib, Qo'shma Shtatlarda turli xil rak ko'rsatkichlari uchun yangi davolash usullarini ishlab chiqishga qaratilgan. Kompaniyaning yetakchi mahsuloti nomzodi galinpepimut-S (GPS) bo'lib, u Wilms tumor 1, antigeniga qarshi yo'naltirilgan peptid immunoterapiyasi; va SLS009 (tambiciclib) bo'lib, u tanlab kichik molekulali siklin-bog'liq kinaza 9, yoki CDK9 ingibitoridir. Kompaniya Merck & Co., Inc. bilan GPS ni PD1 blokatori pembrolizumab bilan birgalikda 1/2 faza klinik sinovida baholash bo'yicha strategik hamkorlikka ega, unda beshta rak ko'rsatkichlari, shu jumladan gematologik malignliklar va qattiq o'smalari bo'lgan bemorlar qatnashadi; GFH009 ni ishlab chiqish va tijoratlashtirish uchun GenFleet Therapeutics (Shanghai), Inc.; va MSK ning WT1 peptidli vaktsina texnologiyasini ishlab chiqish va tijoratlashtirish uchun Memorial Sloan Kettering Cancer Center. SELLAS Life Sciences Group, Inc. Nyu-York, Nyu-Yorkda joylashgan.
| Ism | Lavozim |
|---|---|
| Dr. Angelos M. Stergiou M.D., ScD h.c. | Founder, President, CEO & Director |
| Dr. Dragan Cicic M.D., MBA | Senior VP & Chief Development Officer |
| Mr. Andrew Elnatan | Senior VP of Regulatory Affairs, CMC & Quality |
| Mr. John Thomas Burns CPA | Senior VP & CFO |
| Ms. Stacy E. Yeung | VP, General Counsel & Corporate Secretary |
| Sana | Turi | Hujjat |
|---|---|---|
| 2026-05-12 | 8-K | sls-20260512.htm |
| 2026-04-23 | DEFA14A | tm261477d3_defa14a.htm |
| 2026-03-20 | S-3ASR | tm269045d1_s3asr.htm |
| 2026-03-19 | 8-K | sls-20260319.htm |
| 2026-03-19 | 10-K | sls-20251231.htm |
| 2026-03-11 | 8-K | tm268596d1_8k.htm |
| 2026-01-08 | 8-K | tm262494d1_8k.htm |
| 2025-11-21 | CORRESP | filename1.htm |
| 2025-11-12 | 10-Q | sls-20250930.htm |
| 2025-10-10 | S-3 | tm2528102d1_s3.htm |